secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0000097745-23-000003
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher Q4 revenue $11.45B (+7% YoY), adjusted EPS $5.40; FY2023 guidance: rev $45.3B
--------------------------------------------------------------------------------

- Q4 revenue $11.45B (+7% YoY); GAAP EPS $4.01 (vs $4.17), adjusted EPS $5.40 (vs $6.54).
- Full year revenue $44.92B (+15% YoY); GAAP EPS $17.63 (vs $19.46), adjusted EPS $23.24 (vs $25.13).
- Core organic revenue growth 14% in Q4 and FY2022; COVID-19 testing revenue $0.37B Q4, $3.11B FY.
- FY2023 guidance: revenue ~$45.3B, Core organic growth 7%, adjusted EPS $23.70.
- Completed acquisition of The Binding Site for $2.7B shortly after year-end; PPD integration on track.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774523000003/0000097745-23-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774523000003/tmo-20230201.htm
  HTML page:      https://secwatch.observer/filing/0000097745-23-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer